| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 114.953 | 77 |
| GSM780708 | Untreated after 4 days (C2_1) | 87.2394 | 73 |
| GSM780709 | Untreated after 4 days (C3_1) | 85.9808 | 73 |
| GSM780719 | Untreated after 4 days (C1_2) | 123.41 | 78 |
| GSM780720 | Untreated after 4 days (C2_2) | 110.919 | 77 |
| GSM780721 | Untreated after 4 days (C3_2) | 94.4909 | 74 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 109.141 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 105.464 | 76 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 108.163 | 76 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 96.0667 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 119.195 | 78 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 127.657 | 78 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 95.1576 | 74 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 93.6049 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 85.7654 | 73 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 96.3999 | 75 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 95.9894 | 75 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 105.675 | 76 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 116.248 | 77 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 104.551 | 76 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 98.0699 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 99.1652 | 75 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 110 | 77 |